Yanyan Wang
Psychiatric/Mental Health · Center Line, MINPI 1043806045
Payments from drug & device makers
Across 208 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$686
- Neurocrine Biosciences, Inc.$680
- Otsuka America Pharmaceutical, Inc.$325
- Vanda Pharmaceuticals Inc.$278
- Teva Pharmaceuticals USA, Inc.$272
- Johnson & Johnson$196
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,74998%
- Education$802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $686 |
| Neurocrine Biosciences, Inc. | 41 | $680 |
| Otsuka America Pharmaceutical, Inc. | 18 | $325 |
| Vanda Pharmaceuticals Inc. | 11 | $278 |
| Teva Pharmaceuticals USA, Inc. | 13 | $272 |
| Johnson & Johnson | 10 | $196 |
| Axsome Therapeutics, Inc. | 8 | $162 |
| Lundbeck LLC | 8 | $143 |
| Boston Scientific | 1 | $143 |
| Indivior Inc. | 6 | $133 |
| E.r. Squibb & Sons, L.L.C. | 5 | $127 |
| Alkermes, Inc. | 5 | $121 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| Corium, LLC | 5 | $71 |
| Noven Therapeutics, LLC | 3 | $54 |
| Luye Pharma (USA) Ltd. | 3 | $46 |
| Neos Therapeutics, LP | 2 | $30 |
| Braeburn Inc. | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $20 |
| Validus Pharmaceuticals LLC | 1 | $19 |
| OWP Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$3,828 in reported general payments places this provider in the 85th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 24 | $66,164 |
| TrintellixVortioxetine Hydrobromide | 20 | $11,165 |
| Aripiprazole | 34 | $2,176 |
| Quetiapine Fumarate | 100 | $1,430 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $1,361 |
| Divalproex Sodium ErDivalproex Sodium | 29 | $1,244 |
| Mirtazapine | 48 | $850 |
| Olanzapine | 41 | $846 |
| Bupropion XlBupropion Hcl | 27 | $612 |
| Fluphenazine Hcl | 11 | $581 |
| Duloxetine Hcl | 21 | $559 |
| Bupropion Hcl | 28 | $506 |
| Buspirone Hcl | 45 | $493 |
| Hydroxyzine Hcl | 17 | $474 |
| Clonazepam | 69 | $399 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $196 | $66,16424 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $102 | $11,16520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 638 psychiatric/mental health providers in Michigan.
Other psychiatric/mental health in Center Line
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
- Cynthia MaiSaginaw$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.